Arteriosclerosis
Not recruitingStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
- Disease:Arteriosclerosis
- Substances:Inclisiran
Czechia- Participants:18–64 years · 65+ years
- Substances:Inclisiran
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Czechia52 clinical trials in Nachod, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hypertriglyceridemia and cardiovascular health, evaluating innovative treatments for managing lipid levels and preventing adverse cardiovascular events.
Multiple studies are testing new compounds like plozasiran and olezarsen for triglyceride reduction.
Comprehensive research into chronic skin conditions, with emphasis on plaque psoriasis and atopic dermatitis treatments.
Studies evaluate long-term safety and efficacy of novel therapeutic agents for persistent skin conditions.
Investigations into treatments for chronic kidney disease and heart failure, with particular focus on combination therapies.
Research includes innovative approaches to managing complex chronic conditions and their complications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.